Micrornas For The Treatment Of Heart Diseases

  • Published: Mar 8, 2017
  • Earliest Priority: Sep 01 2015
  • Family: 7
  • Cited Works: 25
  • Cited by: 0
  • Cites: 5
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The invention relates to the field of molecular biology and medicine, more specifically the invention is directed towards the treatment, delay and amelioration of heart diseases. More in particular, microRNAs are provided that induce cardiac regeneration by inducing cell cycle proliferation of cardiomyocytes, thereby treating or ameliorating heart diseases associated with a loss of cardiomyocytes or cardiomyocyte function. Such diseases include myocardial infarction, cardiomyopathy of ischemic or nonischemic origin, myocarditis and heart failure. More in particular, the invention relates to a composition comprising a microRNA selected from the group consisting of microRNA 106b, microRNA 93 or microRNA 25 and the complements thereof, for use in the treatment, prevention, delay or amelioration of a heart disease.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Mar 8, 2017
  • Application: Sep 1, 2015
    EP EP 15183318 A
  • Priority: Sep 1, 2015
    EP EP 15183318 A

Download Citation


Sign in to the Lens

Feedback